Indoco-Remedies Stock/Share Prices, Buy and Sell Indoco-Remedies BSE Stocks

Market Snapshot

BSE Sensex: 40685.5 0.31%
BSE 500: 15539.3 0.33%
BSE 200: 5016.03 0.31%
BSE 100: 11993.48 0.33%
BSE Mid-Cap: 14976.1 0.59%
BSE Small-Cap: 15134.59 0.71%
BANKEX: 27785.94 -0.06%
BSE IT Sector: 21737.93 -0.24%
Nifty 50: 11930.35 0.28%
Nifty 500: 9780.35 0.36%
Nifty 200: 6144.05 0.34%
Nifty 100: 12006.1 0.29%
Nifty Midcap 100: 17306.2 0.79%
Nifty Small 100: 5994.1 0.62%
Nifty IT: 21523.6 0.51%
Nifty PSU Bank: 1319.65 0.47%

News:

Yes Bank posts Q2 PAT at Rs 12...
Tech Mahindra Q2 PAT declines ...
JSW Steel Q2 PAT slides 38% Yo...
Chennai Petroleum Corporation ...
Vishal Fabrics Ltd leads loser...

Indoco Remedies Ltd NSE / BSE
Pharmaceuticals, Small Cap

Invest

23 Oct 2020 | 03:59 PM

255.10

-4.00 (-1.54%)

Add to Watchlist

This awesome feature is still in our labs.
Set Alert

This awesome feature is still in our labs.

Outperforms Index

70.75%

Return (1Y)

Beaten S&P BSE Healthcare by 18.06%
More Volatile

4.17%

Standard Deviation (1Y)

Higher than S&P BSE Healthcare by 2.51%
Not so consistent

5/12

Months

underperformed S&P BSE Healthcare
AxisDirect View

No View

52 Week High-Low

295

140

News & Announcements

Indoco Remedies announces board meeting date
5 days ago

Indoco Remedies announces board meeting date

19 - Oct - 2020 12:00 AM | 5 days ago

Indoco Remedies will hold a meeting of the Board of Directors of the Company on 6 November 2020.
Powered by Capital Market - Live News
Indoco Remedies appoints director
21 days ago

Indoco Remedies appoints director

03 - Oct - 2020 12:00 AM | 21 days ago

Indoco Remedies announced the appointment of Abhijit Yashwant Gore (DIN: 00301688) as an Additional Director (Independent and Non]Executive) of the Company for a term of five consecutive years w.e.f. 03 October 2020.
Powered by Capital Market - Live News
Indoco Remedies director resigns
24 days ago

Indoco Remedies director resigns

30 - Sep - 2020 12:00 AM | 24 days ago

Indoco Remedies announced that Sharad P Upasani, Non]Executive Independent Director of the Company after the cessation of his tenure,retires with effect from 30 September, 2020.
Powered by Capital Market - Live News
Indoco Remedies launches FEVINDO (Favipiravir) 400 mg tablets in India
26 days ago

Indoco Remedies launches FEVINDO (Favipiravir) 400 mg tablets in India

28 - Sep - 2020 12:00 AM | 26 days ago

Indoco Remedies announced the launch of FEVINDO (Favipiravir) 400 mg Tablets in India. Fevindo ] 400 (Favipiravir) is an antiviral drug, effectiveagainst the RNA]based influenza virus. The drug has been approved by DCGI in the treatment of Covid]19. Fevindo 400 reduces pill burden by 50% and ensures convenient dosing and better patient compliance.
Powered by Capital Market - Live News

Price vs Volume

Stock Trivia

FII shareholding in Indoco Remedies Ltd has increased by 11.04% since past 3 Months
FII shareholding in Indoco Remedies Ltd has increased by 7.61% since past 1 Year
MF shareholding in Indoco Remedies Ltd has increased by 7.11% since past 1 Year

Peer Comparison on Risk - Return

Thanks for Liking, Please spread your love by sharing...

General Notifications

My Notifications

Research Notifications

Indoco Remedies Ltd NSE / BSE Pharmaceuticals, Small Cap

255.10 -4.00 (-1.54%)

News & Announcements

Price vs Volume

Stock Trivia

Indoco Remedies Ltd NSE / BSE
Pharmaceuticals, Small Cap

255.10

-4.00 (-1.54%)